SouthernWorldwide.com – A recent study has revealed that a particular “longevity gene” might offer protection to the brain against the effects of aging, including Alzheimer’s disease.
The gene in question is APOE, which stands for apolipoprotein E. Its primary function in the body is to facilitate the transport and metabolism of fats and cholesterol, with a notable role in the brain.
While a specific variant, APOE4, is widely recognized for its strong association with an increased risk of developing Alzheimer’s disease, another variant, APOE2, appears to confer a reduced risk.
Researchers at the Buck Institute for Research on Aging sought to understand the underlying mechanisms behind this protective effect. Utilizing human brain cells derived from stem cells, they made a significant discovery.
Their findings indicated that the APOE2 gene enhances the ability of neurons to repair DNA damage. Furthermore, it helps these cells resist “cellular senescence,” a process where cells age and become worn out.
Conversely, brain cells carrying the APOE4 variant were observed to be more vulnerable. These cells exhibited a greater propensity to display signs of aging and dysfunction, according to the research team.
These initial findings were further corroborated by subsequent studies conducted on mice, lending additional weight to the research.
“APOE is well-known for its role in cholesterol transport, but the newly identified mechanism could partially explain why APOE2 carriers tend to have longer lifespans and a lower risk of Alzheimer’s.”
Read more : Super Bowl Champion Craig Morton's Cause of Death Revealed at 83
The researchers expressed considerable surprise at discovering that the protective mechanism of APOE2 in neurons involved DNA signaling and repair. This was unexpected given the gene’s established association with cholesterol metabolism.
“APOE2 is so widely recognized for cholesterol transport that uncovering this major pathway, and seeing it consistently observed across various human neuron models and aged mice, was striking for us,” stated Ellerby.
The study also demonstrated that introducing the APOE2 protein to APOE4 neurons helped reduce their DNA damage following exposure to radiation stress.
These results suggest that future therapeutic interventions could focus on mimicking the protective effects of APOE2. Alternatively, treatments might aim to bolster the brain’s DNA repair systems, particularly for individuals who carry the higher-risk APOE4 gene.
The comprehensive findings of this study have been published in the esteemed journal Aging Cell, making them accessible to the scientific community.
Christopher Weber, PhD, who holds the position of senior director of global scientific initiatives at the Alzheimer’s Association in Chicago, described the study as “exciting and significant.”
He further noted that the Alzheimer’s Association is currently supporting 13 ongoing research projects across four different countries. These projects are dedicated to investigating the specific role of APOE2 in offering protection against Alzheimer’s disease.
Caghan Kizil, PhD, an associate professor of neurological sciences at Columbia University Vagelos College of Physicians and Surgeons, recently secured a substantial $500,000 grant. This funding from the American Brain Foundation will be instrumental in supporting his research related to the APOE4 gene.
Dr. Kizil concurred that these findings may provide valuable insights into why certain brains maintain their health for extended periods compared to others. He also highlighted how natural protective mechanisms can contribute to sustained brain health over time.
“What I find especially interesting is the idea that Alzheimer’s may partly reflect the brain losing its ability to stay resilient with age,” he commented. “Growing evidence in the field suggests that APOE-related risk is not only about amyloid buildup, but also about how aging, inflammation, blood vessel health, and the brain’s repair systems work together over time.”
Weber suggested that future research endeavors could delve into identifying the factors that contribute to natural brain resilience. The ultimate goal, he added, is to explore whether these protective mechanisms can be harnessed to assist individuals who carry higher-risk genes like APOE4.
“In other words, the long-term goal is to help vulnerable brains age more like resilient brains,” he elaborated. “We believe the future of Alzheimer’s research lies in preventing at-risk individuals from developing the disease in the first place.”
The researchers acknowledged certain limitations inherent in their new study. The primary constraint was that the research was not conducted on living patients, which means direct clinical application requires further investigation.
The researchers also cautioned individuals against making immediate lifestyle changes solely based on this study’s findings. They specifically advised against undergoing genetic testing for APOE with the sole purpose of achieving longevity.
“The results are complex and difficult to interpret,” Ellerby noted. “The broader message is that supporting your brain’s DNA repair and slowing cellular senescence are beneficial for your overall health.”
The study suggests that several healthy practices can contribute to these goals. These include engaging in regular exercise, ensuring optimal sleep patterns, maintaining good cardiovascular health, and avoiding exposure to “genotoxic” agents such as cigarette smoke.
“These are all incredibly beneficial for your health, irrespective of your specific APOE variant,” the researcher concluded, emphasizing the universal health benefits of these lifestyle choices.
